ClinVar Miner

Variants studied for Combined oxidative phosphorylation defect type 21

Coded as:
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
12 22 16 1 1 35

Gene and significance breakdown #

Total genes and gene combinations: 1
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign total
TARS2 12 22 16 1 1 35

Submitter and significance breakdown #

Total submitters: 12
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign total
Houlden Lab, UCL Institute of Neurology 1 12 4 0 0 17
OMIM 12 0 0 0 0 12
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet 1 7 0 0 0 8
Baylor Genetics 0 0 5 0 0 5
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute 1 0 3 0 0 4
Revvity Omics, Revvity 0 1 2 0 0 3
Undiagnosed Diseases Network, NIH 0 2 0 0 0 2
Neuberg Centre For Genomic Medicine, NCGM 0 0 2 0 0 2
Fulgent Genetics, Fulgent Genetics 0 0 0 1 0 1
Genetics and Molecular Pathology, SA Pathology 0 1 0 0 0 1
Department Of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University 0 0 1 0 0 1
Genome-Nilou Lab 0 0 0 0 1 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.